IFITM3/Fragilis Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-89401
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Format
Concentration
Product Specifications
Immunogen
Reactivity Notes
Clonality
Host
Isotype
Scientific Data Images for IFITM3/Fragilis Antibody - BSA Free
Western Blot: IFITM3/Fragilis Antibody [NBP1-89401]
Western Blot: IFITM3/Fragilis Antibody [NBP1-89401] - Analysis in human cell lines SK-MEL-30 and Caco-2 using anti-IFITM3 antibody. Corresponding IFITM3 RNA-seq data are presented for the same cell lines. Loading control: anti-HDAC1.Immunohistochemistry-Paraffin: IFITM3/Fragilis Antibody - BSA Free [NBP1-89401]
Staining of human cervix, uterine shows strong cytoplasmic granular positivity in squamous epithelial cells.Immunohistochemistry-Paraffin: IFITM3/Fragilis Antibody - BSA Free [NBP1-89401]
Staining of human fallopian tube shows strong cytoplasmic granular positivity in glandular cells.Applications for IFITM3/Fragilis Antibody - BSA Free
Immunohistochemistry
Immunohistochemistry-Paraffin
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Format
Preservative
Concentration
Shipping
Stability & Storage
Background: IFITM3/Fragilis
Mouse IFITM3/CD225 (also Fragilis) is a 137 amino acids (aa) 2-transmembrane protein that belongs to the Fragilis family of interferon-inducible genes. It contains two terminal extracellular domains (aas 1 - 57 and 131 - 137) and one cytoplasmic region that potentially allows for multiple phosphorylations. The N-terminal extracellular region of mouse IFITM3 is 54%, 91% and 58% aa identical to the equivalent region in bovine, rat and human IFITM3, respectively. IFITM3 is believed to be involved in primordial germ cell clustering and regionalization.
Long Name
Alternate Names
Gene Symbol
Additional IFITM3/Fragilis Products
Product Documents for IFITM3/Fragilis Antibody - BSA Free
Product Specific Notices for IFITM3/Fragilis Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.